Navigation Links
Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
Date:4/10/2008

SAN FRANCISCO, April 10 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that positive preclinical and clinical results for its pipeline programs will be presented at numerous medical and scientific meetings over the coming months. These presentations will highlight Nektar's novel therapeutic candidates in the areas of oncology, anti-infectives and central nervous system (CNS), which leverage Nektar's innovative small molecule PEGylation and liquid aerosol platforms.

The data presentations are as follows:

-- April 12-16, 2008: Presentation of Positive Preclinical Data for NKTR-102 (PEG-irinotecan) at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, California:

Poster #766: "Enhanced anti-tumor activity of NKTR-102, a novel

PEGylated-irinotecan, when administered in combination with

bevacizumab in a mouse model of human colorectal tumors"

Poster #5741: "NKTR-102, a novel PEGylated-irinotecan, has an

enhanced pharmacokinetic profile with reduced gastrointestinal and

hematopoietic toxicity compared to irinotecan with repeat dosing"

Poster #5742: "NKTR-102, a novel PEGylated-irinotecan, has a

superior acute safety, tolerability, and pharmacokinetic profile

compared to irinotecan"

-- May 8-10, 2008: Presentation of Phase 1 Clinical Trial Multi-Dose Safety Data for NKTR-118 (oral PEG-naloxol) in Opioid Bowel Dysfunction at the American Pain Society (APS) Meeting in Tampa, Florida:

Poster #210: "Results from a phase I, double-blind, randomized,

placebo-controlled, multiple-dose study evaluating the safety,

t
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
8. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, ... and contracting company, awarded several new IT value-added ... to provide hospital organizations with IT goods and ... and service agreements, as well as value-added services ... support. New Novation agreements were ...
(Date:1/15/2014)... 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ... human genetics, genomic technology, and drug discovery to ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ... practice of dermatology for clinical and aesthetic dermatology practitioners ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... The Pittsburgh Life Sciences Greenhouse (PLSG), the ... and business growth programs to western Pennsylvania,s life ... nationally recognized Executives-in-Residence (EIR) has launched a new ... (Ib2C(TM)). Ib2C(TM) Founder and CEO, Stephen ...
... GAITHERSBURG, Md., Sept. 21 New school schedules, exciting sporting ... this fall. But how many have taken time to get ... and Prevention (CDC) advises that flu vaccination begin as soon ... time, the CDC recommends every eligible American ages six months ...
Cached Medicine Technology:Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company 2Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company 3Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company 4National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall 2National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall 3National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall 4National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall 5
(Date:3/12/2014)... Los Angeles, CA (March 12, 2014) Researchers have found ... and stronger healing of Achilles tendon tears than traditional ... March 2014 issue of Foot & Ankle International ... common for professional, collegiate and recreational athletes. These injuries ... tendon if it has been torn. Patients have ...
(Date:3/10/2014)... living well into their 90s, the number of ... increase. In the study, "Total Hip Arthroplasty Proves ... at the 2014 Annual Meeting of the American ... characteristics and rates of postoperative morbidity, mortality and ... between April 2001 and December 2011. , ...
(Date:3/10/2014)... STANFORD, Calif. Some sour news for lactose-intolerant people ... stomach than pasteurized milk: A pilot study from the ... digestibility between the two. , The study was small ... investigator said the results were highly consistent among all ... raw, or unpasteurized, milk. , "It,s not that there ...
(Date:3/10/2014)... 2014 If you,re having some drinks this St. Patrick,s ... may end up on the business end of a breathalyzer ... can beat it, think again; chemistry will land you in ... we examine how your breath can get you busted when ... here: http://youtu.be/rvVzlg26bCM , Subscribe to the series at ...
(Date:3/9/2014)... 2014) Irritable bowel syndrome (IBS) belongs to the ... to sixty per cent of the workload of ... of IBS is bloating, which reduces quality of ... bothersome. For quite a long time, IBS was ... "Contrary to this view, recent findings suggest that ...
Breaking Medicine News(10 mins):Health News:Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds 2Health News:Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds 3Health News:Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds 4Health News:IBS and bloating: When the gut microbiota gets out of balance 2Health News:IBS and bloating: When the gut microbiota gets out of balance 3
... after medications have reached millions, study says , , ... drugs that are approved quickly to meet mandated deadlines are ... after they are in millions of Americans, medicine cabinets, ... not necessarily the case that these drugs should not have ...
... Those accepted early on by friends grow up healthier ... (HealthDay News) -- New research suggests that a child,s ... more likely to contribute to anxiety and depression than ... young adulthood. , The study, conducted by researchers at ...
... Ala., March 26 Emageon Inc.,(Nasdaq: ... information technology,systems for hospitals and healthcare networks, ... the "Best in KLAS" award for,Cardiology PACS*. ... and,pediatric cardiovascular tools offering cardiovascular information,management, hemodynamic ...
... 26 Toxikon Corporation will host,their second ... 17 at their,headquarters in Bedford, Massachusetts., ... safety-testing guidelines continue to be updated and ... requirements,appropriate for their product. With new innovations ...
... hairdressers, barbers , , WEDNESDAY, March 26 (HealthDay News) -- ... had high concentrations of coloring ingredients appear to be ... new report contends. , The authors said the findings ... -- that hair dyes appear to increase the risk ...
... of its kind for the genetic roots of inflammatory bowel ... as further evidence that some people of Jewish descent are ... in DNA associated with the two most common forms of ... frequently marked by inflammation of the final section of the ...
Cached Medicine News:Health News:Drugs Approved Under Deadline More Likely to Run Into Trouble Later 2Health News:Drugs Approved Under Deadline More Likely to Run Into Trouble Later 3Health News:Drugs Approved Under Deadline More Likely to Run Into Trouble Later 4Health News:Social Problems in Youth Contribute to Anxiety, Depression 2Health News:Emageon Receives 'Best in KLAS' Cardiology PACS Award 2Health News:Now-Banned Hair Dyes Linked to Bladder Cancer 2Health News:Large multicenter study suggests new genetic markers for Crohn's disease 2
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
... System is a rapid, real-time thermal cycler ... samples. By automating much of the testing ... programmable, it is the fastest, easiest to ... the market. The SmartCycler delivers highly accurate ...
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... Thermal Block and its operation software ... quantification of gene expression, genotyping, counting ... of microarray results. Exicycler is capable ... molecules, such as protein-protein and protein-ligand, ...
Medicine Products: